AVR 0.00% $18.00 anteris technologies ltd

HSV Vaccine Results, page-70

  1. 6,439 Posts.
    lightbulb Created with Sketch. 42
    Really, so I should say nothing, what happened to a debate should I only post your point of view??
    what about what I was referring to or are we not talking facts like some haven't bothered to do

    - The continued uptake of CardioCel® into European and US surgical centres
    - Additional market approvals for CardioCel®, including Singapore and Canada;
    - Growing the manufacturing capabilities at the Malaga manufacturing site;
    - Expanding the uses for CardioCel® within the cardiovascular therapeutic area;
    - Continuing product development of other ADAPT products to expand the regenerative tissue portfolio;
    - Progressing the clinical development of the therapeutic vaccines, in particular the HSV-2 vaccine into a Phase II clinical study and the HPV therapeutic vaccine into a Phase I study.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.